APO-AMBRISENTAN
APO-AMBRISENTAN
Approved
DIN Number
02475375
Drug Class
Human
Market Date
Nov 26, 2018
Company
HC
Apotex Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02475375
AIG Number0152452001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C02KX02 AMBRISENTAN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification48:48.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
AMBRISENTANActive
Strength: 5 MG
Monograph: AMBRISENTAN